RecalledThisWeek Search
Medium risk Drugs & MedicationsClass II

ACCORD HEALTHCARE, INC. Recall

Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bottles (NDC 16729-457-15) and b) 1000-count bottles (NDC 16729

Updated August 6, 2026

ACCORD HEALTHCARE, INC. is recalling Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bottles (NDC 16729-457-15) and b) 1000-count bottles (NDC 16729. Hazard: Subpotent Drug

Is the ACCORD HEALTHCARE, INC. recalled? Yes. This product was recalled by FDA on August 6, 2026. Details below.

What is recalled

Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bottles (NDC 16729-457-15) and b) 1000-count bottles (NDC 16729-457-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India.

Am I affected

You may be affected if you own this product. Check the brand, model, and lot/date codes listed in the recall against your item.

What to do right now

Voluntary: Firm initiated

The hazard

Subpotent Drug

Brands affected

ACCORD HEALTHCARE, INC.
Source
FDA
Category
Drugs & Medications
Recall ID
fda-D-0785-2026
Classification
Class II
Recalled
August 6, 2026
Read the official notice

Get free recall alerts

New Drugs & Medications recalls, the moment they post.

Free forever. Unsubscribe anytime. We never sell your data.

More Drugs & Medications recalls